ロード中...
Safety profile of biologic therapy in Polish paediatric patients with Crohn's disease
INTRODUCTION: In recent years, monoclonal antibodies against tumor necrosis factor α (TNF-α), infliximab (IFX), and adalimumab (ADA) have gained increasing popularity in Crohn's disease (CD) management. Many clinical trials have shown that biologics are a generally well-tolerated and safe treat...
保存先:
| 出版年: | Prz Gastroenterol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Termedia Publishing House
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4607696/ https://ncbi.nlm.nih.gov/pubmed/26516383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pg.2015.52298 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|